ASX:IVC - InvoCare Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
A$13.39 +0.18 (+1.36 %)
(As of 06/20/2018 04:00 PM ET)
Previous CloseA$13.39
Today's RangeA$13.28 - A$13.50
52-Week RangeA$13.50 - A$18.15
Volume530,358 shs
Average Volume559,236 shs
Market Capitalization$1.53 billion
P/E RatioN/A
Dividend Yield3.31%
BetaN/A
InvoCare Limited provides funeral, cemetery, crematoria, and related services in Australia, New Zealand, and Singapore. The company operates 270 funeral home locations, and 16 cemeteries and crematoria under various brands. It also offers HeavenAddress, an online memorial community; LifeArt coffins; and Guardian Plan, a prepaid funeral plan, which enables prepay selected funeral services. In addition, the company operates MyGriefAssist, an online grief resource Website; MyMemorial, a Website that provides range of cremation and burial memorial options; Funeral Planner, a digital funeral planning service; and FuneralAdvice that provides information on funerals and related topics. InvoCare Limited is headquartered in North Sydney, Australia.

Receive IVC News and Ratings via Email

Sign-up to receive the latest news and ratings for IVC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Personal Services
Sub-IndustryN/A
SectorServices
SymbolASX:IVC
CUSIPN/A
Phone+61-2-99785200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins22.96%
Return on Equity42.13%
Return on Assets9.63%

Miscellaneous

EmployeesN/A
Outstanding Shares109,700,000

InvoCare (ASX:IVC) Frequently Asked Questions

What is InvoCare's stock symbol?

InvoCare trades on the ASX under the ticker symbol "IVC."

Who are some of InvoCare's key competitors?

Who are InvoCare's key executives?

InvoCare's management team includes the folowing people:
  • Mr. Martin Alistair John Earp B.Sc., M.B.A., M.Sc., CEO, MD & Exec. Director (Age 49)
  • Ms. Josée Lemoine BCom, Chief Financial Officer
  • Mr. Graeme Rhind, Chairman of New Zealand
  • Mr. Phillip Friery BBus, CA, Company Sec.
  • Ms. Leng Goh Wee, Chief Exec. Officer of Singapore Casket Company

Has InvoCare been receiving favorable news coverage?

News headlines about IVC stock have been trending somewhat positive on Wednesday, Accern Sentiment reports. Accern ranks the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. InvoCare earned a media sentiment score of 0.19 on Accern's scale. They also gave press coverage about the company an impact score of 46.59 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

What is InvoCare's stock price today?

One share of IVC stock can currently be purchased for approximately A$13.39.

How big of a company is InvoCare?

InvoCare has a market capitalization of $1.53 billion.

How can I contact InvoCare?

InvoCare's mailing address is L 2 40 Miller St, NORTH SYDNEY, NSW 2060, Australia. The company can be reached via phone at +61-2-99785200.


MarketBeat Community Rating for InvoCare (IVC)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  38 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  72
MarketBeat's community ratings are surveys of what our community members think about InvoCare and other stocks. Vote "Outperform" if you believe IVC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.